Functions and Evolution of Selenoprotein Methionine Sulfoxide Reductases by Cheon Lee, Byung et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Vadim Gladyshev Publications Biochemistry, Department of 
2009 
Functions and Evolution of Selenoprotein Methionine Sulfoxide 
Reductases 
Byung Cheon Lee 
University of Nebraska-Lincoln 
Alexander Dikiy 
Norwegian University of Science and Technology 
Hwa-Young Kim 
Aging-associated Vascular Disease Research Center, Yeungnam University College of Medicine, Daegu 
705-717, Republic of Korea 
Vadim N. Gladyshev 
University of Nebraska-Lincoln, vgladyshev@rics.bwh.harvard.edu 
Follow this and additional works at: https://digitalcommons.unl.edu/biochemgladyshev 
 Part of the Biochemistry, Biophysics, and Structural Biology Commons 
Cheon Lee, Byung; Dikiy, Alexander; Kim, Hwa-Young; and Gladyshev, Vadim N., "Functions and Evolution 
of Selenoprotein Methionine Sulfoxide Reductases" (2009). Vadim Gladyshev Publications. 94. 
https://digitalcommons.unl.edu/biochemgladyshev/94 
This Article is brought to you for free and open access by the Biochemistry, Department of at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Vadim Gladyshev 
Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
1. Introduction
Cellular components in aerobic organisms are often con-
fronted with reactive oxygen species (ROS) and reactive nitro-
gen intermediates (RNI). Molecular oxygen is indispensible for 
survival of aerobic organisms, which use it for respiration and 
numerous other processes, but the use of oxygen is also asso-
ciated with the generation of ROS [1]. ROS may damage vari-
ous biomolecules, such as DNA, proteins, and lipids, and may 
contribute to the development of cancer, neurodegenerative dis-
eases and other maladies. Oxidative damage to DNA may lead 
to mutations, which in turn may result in cancer [2, 3]. Lipid ox-
idation by ROS may change membrane rigidity and permeabil-
ity. In addition, it may disrupt membrane networks and gen-
erate toxic products, such as malondialdehyde, through lipid 
peroxidation [4, 5]. Oxidized proteins may become nonfunc-
tional due to structural changes and catalytic malfunction. Sul-
fur-containing amino acids, methionine and cysteine, are the 
major targets of ROS and are the amino acids most susceptible 
to oxidation. Oxidized methionine exists in the form of two dia-
stereomers, methionine-S-sulfoxide and methionine-R-sulfoxide 
[6, 7]. To counteract ROS damage, organisms evolved defense 
systems, including low molecular weight compounds and anti-
oxidant enzymes that protect against oxidative stress. The lat-
ter include glutathione peroxidase (GPx) [8, 9], superoxide dis-
mutase (SOD) [10, 11], catalase [12], thioredoxin reductase (TR) 
[13], methionine sulfoxide reductase (Msr) [14–17], and several 
other proteins. Among these antioxidant enzymes, Msrs are 
prominent because of their roles as repair enzymes and indirect 
scavengers of ROS. These proteins utilize catalytic redox-active 
cysteine residues to reverse oxidized methionine back to methi-
onine. Many Msrs use the thioredoxin system in vivo to regener-
ate the active catalytic cysteine, but other reductants may also be 
used [16–20]. Because of their protein repair functions, the stud-
ies involving Msrs are broadly linked to various research areas 
such as aging, neurodegenerative disease, cancer, cell signaling, 
and protein function.
2. Three types of methionine sulfoxide reductases
The first Msr enzyme, MsrA, was discovered some 30 years 
ago. It was found that this enzyme can restore the function of ox-
idized ribosomal protein L12 in Escherichia coli [21]. After this ini-
tial finding, Msrs have been investigated from a variety of or-
ganisms, new Msr forms were discovered, and currently these 
enzymes can be divided into three large groups according to their 
substrate specificity and family clustering. MsrA is specific for the 
reduction of free and protein-based methionine-S-sulfoxide. This 
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Abstract
Methionine sulfoxide reductases (Msrs) are thiol-dependent enzymes which catalyze conversion of methionine sulfoxide to methionine. Three 
Msr families, MsrA, MsrB, and fRMsr, are known. MsrA and MsrB are responsible for the reduction of methionine-S-sulfoxide and methionine-
R-sulfoxide residues in proteins, respectively, whereas fRMsr reduces free methionine-R-sulfoxide. Besides acting on proteins, MsrA can addi-
tionally reduce free methionine-S-sulfoxide. Some MsrAs and MsrBs evolved to utilize catalytic selenocysteine. This includes MsrB1, which is a 
major MsrB in cytosol and nucleus in mammalian cells. Specialized machinery is used for insertion of selenocysteine into MsrB1 and other seleno-
proteins at in-frame UGA codons. Selenocysteine offers catalytic advantage to the protein repair function of Msrs, but also makes these proteins 
dependent on the supply of selenium and requires adjustments in their strategies for regeneration of active enzymes. Msrs have roles in protecting 
cellular proteins from oxidative stress and through this function they may regulate lifespan in several model organisms.
Keywords: methionine sulfoxide, MsrA, fRMsr, MsrB1, MsrB2, MsrB3, selenoprotein, selenocysteine, aging, antioxidants, ROS
1
2 le e e t A l. i nBi o c h i m i c a e t Bi o phy s i c a ac ta (BBa)—Gen er a l su B j ec ts  (2009) 
protein is the only known enzyme in mammals capable of reduc-
ing methionine-S-sulfoxide [22–25], but it can also reduce other 
compounds such as N-acetyl-methionine-S-sulfoxide, dimethyl 
sulfoxide, ethionine-S-sulfoxide, S-sulindac, S-sulforaphane, etc. 
[26–28]. It was found that MsrA exists in a selenoprotein form in 
some lower organisms, such as green algae and bacteria, wherein 
it utilizes catalytic selenocysteine in place of cysteine [29, 30].
A second Msr, known as MsrB (described previously as 
SelR or SelX), is specific for the reduction of protein-based me-
thionine-R-sulfoxide, but also, with low efficiency, of free me-
thionine-R-sulfoxide. For example, catalytic efficiency of E. coli 
MsrB for the reduction of free methionine-R-sulfoxide is 1000-
fold lower than that of E. coli MsrA for free methionine-S-sulf-
oxide. In addition, when the MsrB gene was disrupted in E. coli, 
specific activity of cell extract for the reduction of free methio-
nine-R-sulfoxide was essentially unchanged [31, 32], whereas 
mutation of another Msr gene (see below) in yeast resulted in 
the reduced activity with this substrate [33]. In human SK-Hep1 
cells, MsrBs were also found to be inefficient reductants of free 
methionine-R-sulfoxide. Thus, this study revealed that mam-
mals have important differences in the reduction of free methio-
nine-S-sulfoxide and free methionine-R-sulfoxide [34].
In mammals, there are three MsrB proteins, including MsrB1, 
MsrB2, and MsrB3. All three contain Zn, coordinated by two 
CxxC motifs (i.e., two Cys separated by two residues), which 
stabilizes MsrB structure. Of these three enzymes, MsrB1 is a 
selenoprotein that contains selenocysteine in place of the cata-
lytic cysteine residue normally present in other MsrBs [35, 36].
A third Msr type, fRMsr, was only recently discovered [37] 
and it catalyzes the reduction of free methionine-R-sulfoxide [33, 
34, 37]. This enzyme is a GAF-domain-containing protein and is 
highly specific for its substrate (i.e., it does not act on protein-based 
sulfoxides) [33, 37, 38]. Interestingly, comparative genomic analy-
sis of fRMsr revealed that its occurrence is limited to unicellular 
organisms, whereas multicellular organisms, including mammals, 
lack this protein [33, 37]. This observation suggested that fRMsr 
was lost during evolution in mammals, i.e., they are deficient in 
the reduction of free methionine-R-sulfoxide (Figure 1).
The three Msrs support protein repair and methionine me-
tabolism functions by reducing free and protein-based methio-
nine sulfoxides. The key function of Msr is to repair oxidatively 
damaged proteins, in which ROS oxidized methionine residues. 
This oxidation may interfere with protein function, because it 
leads to an increased negative charge and size, and consequently 
may result in structural changes and loss of function [6, 7, 39]. In 
addition, Msrs may work indirectly as ROS scavengers through 
cyclic oxidation and reduction of methionine residues. The me-
thionine/Msr system may assist other redox systems, such as 
thioredoxin and glutathione systems, in maintaining cellular re-
dox homeostasis. This idea is consistent with the data showing 
that deficiency in various Msrs results in oxidative stress [14, 16, 
40, 41]. Methionine sulfoxides and Msrs may also play a role in 
sensing altered redox status and regulating certain proteins. Re-
cently, it was shown that CaMKII (calcium/calmodulin (Ca2+/
CaM)-dependent protein kinase II) was activated by oxidation 
of its methionine residue in the regulatory domain in the ab-
sence of Ca2+/CaM and that this activation could be reversed by 
MsrA [42]. In addition, human large conductance Ca2+-activated 
K channels (BKCa or Slo), E. coli Ffh, human potassium channel 
HERG1, and calmodulin are known to be regulated by oxida-
tion of methionine residues and the repair activity of Msrs [43–
45]. Along with these Msr functions, several reports showed that 
MsrA knockout mice exhibit a tip-toe walking behavior consis-
tent with cerebellar dysfunction [46], enhanced neurodegener-
ation in hippocampus [47], and impaired dopamine regulation 
[48]. However, the specific link between Msrs and neurodegen-
erative diseases remains poorly understood.
3. Localization of mammalian MsrA and MsrBs
Mammals have a single MsrA gene containing a typical mi-
tochondrial signal peptide [49]. However, mouse and rat Ms-
rAs occur not only in mitochondria, but also in cytosol and nu-
cleus. It was suggested that the rate of folding is a crucial factor 
in the subcellular distribution of MsrA, even though the molec-
ular mechanism and regulation remain unclear [50]. It was also 
reported that alternative first exon splicing generates an addi-
tional MsrA form lacking a mitochondrial signal, which re-
sides in cytosol and nucleus [51–53]. It should be noted, how-
ever, that the alternatively spliced MsrA form was not detected 
in examined mouse tissues, including brain, kidney, and liver, 
by western blot assays, and only a weak signal was detected at 
the mRNA level. Studies showed that other alternative forms of 
MsrA mRNA, such as an additional exon 2, could be detected in 
rat aortic vascular smooth muscle cells and aortic tissue prepa-
rations [53] and that this form was localized exclusively to mito-
chondria [53, 54].
Among three mammalian MsrBs, MsrB1 is present in the cy-
tosol and nucleus and exhibits the highest catalytic activity due 
to selenocysteine in its active site. Recently, it was found that 
MsrB1 occurs in two forms, 14 kDa and 5 kDa, in mouse tissues 
and human HEK 293 cells and that both forms are selenopro-
teins. The 5 kDa form corresponded to a C-terminal sequence of 
the 14 kDa MsrB1. However, neither function nor regulation of 
the 5 kDa MsrB1 is known [55, 56]. MsrB2, also known as CBS1, 
is targeted to mitochondria with the guidance of its N-termi-
nal signal peptide. MsrB2 has cysteine as the catalytic residue. It 
shows high activity with methionine-R-sulfoxide, but is inhibited 
Figure 1. Reversible generation and reduction of methionine sulfoxide. MsrA can reduce both free and protein-based methionine-S-sulfoxide. 
MsrB mainly reduces protein-based methionine-R-sulfoxide and its activity towards free methionine-R-sulfoxide is very weak. fRMsr can only re-
duce free methionine-R-sulfoxide.


























by elevated concentrations of substrate [35, 57, 58]. MsrB3 con-
sists of two forms, MsrB3A and MsrB3B, generated by alterna-
tive first exon splicing in humans. MsrB3A is targeted to the en-
doplasmic reticulum (ER) by an N-terminal ER signal peptide 
and an ER retention signal at the C-terminus, whereas MsrB3B 
is targeted to mitochondria by its N-terminal mitochondrial sig-
nal peptide. Interestingly, mouse MsrB3 also has the ER and mi-
tochondrial signal peptides located consecutively at the N-ter-
minus, but it is targeted only to the ER due to masking of the 
mitochondrial signal by an upstream ER signal. Even though 
a possibility cannot be excluded that small amounts of mouse 
MsrB3 targeted to mitochondria exist, studies found no evidence 
of alternative splicing in this gene based on EST, RT-PCR, and 
western blot analyses [35, 59]. The localization pattern of mam-
malian MsrA and MsrBs is shown in Figure 2.
4. Catalysis by the different Msr types
Mammalian MsrA has three conserved cysteines, which par-
ticipate in the reaction as catalytic and resolving cysteines. A 
sulfenic acid intermediate at the catalytic cysteine is generated 
when this residue attacks the sulfur of methionine-S-sulfoxide 
and then thiol–disulfide exchange involving two resolving cys-
teines leads to a disulfide bond on the protein surface, which 
is finally reduced by thioredoxin or DTT [23, 60]. Recently, it 
was proposed that yeast fRMsr also has three conserved cyste-
ines that follow a similar sulfenic acid/thiol–disulfide exchange 
mechanism. In addition, the thioredoxin system can function in 
recycling fRMsr as it does in the case of MsrA. A difference be-
tween MsrA and fRMsr involves accessibility of the substrate. 
Yeast fRMsr has a narrow binding pocket, which limits access to 
bulky substrates. This may explain differences in substrate spec-
ificity between MsrA and fRMsr, even though the overall cata-
lytic process involving catalytic and resolving cysteines is simi-
lar in these enzymes (Figure 3A and B) [33, 37].
Figure 2. Localization of Msrs in mammals. MsrA and MsrB1 are lo-
cated in the nucleus and cytosol. MsrA, MsrB2, and MsrB3B are tar-
geted to mitochondria by their mitochondrial targeting signals. Hu-
man MsrB3A is located in the ER and has N-terminal ER targeting and 
C-terminal retention signals, whereas human MsrB3B is a mitochon-
drial protein. Mouse MsrB3 is located in the ER. There are alterna-
tively spliced variants of MsrA, which are not shown in the figure and 
localize to cytosol and nucleus, or to mitochondria.
Figure 3. Catalytic mechanisms of Msrs. Catalytic cysteine (CC), resolving cysteine (RC), and/or third cysteine (TC) take part in the catalysis by 
(A) MsrA, (B) fRMsr, (C) MsrB1, and (D) MsrB2 and MsrB3. MsrA and fRMsr have three conserved cysteines. MsrB1 has one conserved cysteine 
and one conserved selenocysteine. MsrB2 and MsrB3 have only one redox cysteine and its intermediate sulfenic acid may be directly reduced by 
thioredoxin or certain compounds.
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MsrB1 has one conserved cysteine in the N-terminal por-
tion and the catalytic selenocysteine in the C-terminal region. 
During catalysis, selenocysteine forms selenenic acid interme-
diate by attacking the sulfur of methionine-R-sulfoxide and 
then this intermediate rearranges into selenenylsulfide with the 
help of the resolving cysteine and is finally reduced by thiore-
doxin (Figure 3C) [61]. In contrast, MsrB2 and MsrB3 have only 
one conserved cysteine and appear to have evolved a different 
catalytic mechanism for the reduction of their sulfenic acid in-
termediate (i.e., without disulfide formation between catalytic 
and resolving cysteines), which is reduced directly by thiore-
doxin (Figure 3D) [61–63]. Although thioredoxin is the most im-
portant reductant for Msrs, it was shown that thioredoxin-in-
dependent Msr reduction is also possible [19, 20]. For example, 
thionein, selenocystamine, and CDP32 could be used for the re-
duction of human MsrB2 and MsrB3, and such thioredoxin-in-
dependent reaction may even be more efficient than that in-
volving thioredoxin.
5. Selenoproteins and catalytic benefits of selenocysteine 
utilization
Selenoproteins exist in organisms in all three domains of life. 
Selenium is inserted into these proteins co-translationally in the 
form of selenocysteine, in response to UGA codon. Selenocyste-
ine insertion is dependent on the presence of a stem-loop struc-
ture, known as the SECIS (selenocysteine insertion sequence) ele-
ment, in the 3′-UTRs of selenoprotein genes. Selenium is essential 
in mammals because of its occurrence in selenoproteins (Figure 4). 
These proteins have various functions and show widely different 
knockout phenotypes. For example, GPx4 reduces lipid peroxides 
and its knockout in mice results in embryonic lethality [64]. An-
other selenoprotein, Selenoprotein P (SelP), transports selenium 
from liver to brain, thyroid gland, kidney, testis and likely other 
organs. Without SelP, a much higher selenium intake is needed to 
support selenoprotein synthesis [65–67]. Selenoprotein N (SelN) 
is a protein of unknown function and mutations in this gene are 
linked to various muscular diseases, such as rigid spine muscular 
dystrophy [68]. Many of the 25 human selenoproteins contribute 
to the regulation of redox homeostasis, but the functions of sev-
eral proteins are not known. Perhaps, the best studied selenopro-
tein families are GPxs and TRs. There are 5 selenoprotein GPxs in 
humans and 4 in mice, which function as thiol-dependent perox-
idases. TR 1, 2, and 3 regulate cellular redox homeostasis by con-
trolling the redox state of thioredoxins [69]. SelW and SelK might 
also play a role in redox regulation. For example, SelW binds glu-
tathione and its overexpression increases resistance to oxidative 
stress in CHO cells and H1299 cancer cells in a glutathione-de-
pendent manner [70, 71]. Overexpression of SelK reduces intra-
cellular ROS levels and protects cardiomyocytes from oxidative 
stress-induced toxicity [72].
Like other functionally characterized selenoproteins, MsrB1 is 
an oxidoreductase. Selenocysteine in this enzyme supports high 
catalytic efficiency of MsrB1 (> 100-fold higher than that of the 
corresponding cysteine-containing mutant) [35, 61, 73, 74]. This 
enhancement of activity was also demonstrated for a selenocyste-
ine-containing MsrA from Chlamydomonas [30]. Thus, selenocyste-
ine, strategically positioned in the active site, is a key catalytic res-
idue, whereas its replacement with cysteine leads to a significant 
drop or loss of catalytic activity. Similar observations were also 
made with iodothyronine deiodinase in oocytes [75, 76] and clos-
tridial glycine reductase selenoprotein A [75, 77].
However, selenocysteine is not always beneficial under phys-
iological conditions. When the catalytic cysteine in MsrB2 and 
MsrB3 was replaced with selenocysteine, activities of these en-
zymes were increased up to 100-fold in the presence of DTT as 
a reducing agent, but these proteins were not active with thio-
redoxin. One possibility is that a selenenic acid intermediate 
could not be efficiently reduced by thioredoxin and therefore 
the enzymes could not be regenerated for the next catalytic cy-
cle, whereas a selenenylsulfide bond, formed between catalytic 
selenocysteine and resolving cysteine residues, was reducible 
by thioredoxin. This hypothesis was recently supported by the 
studies on a natural selenocysteine-containing MsrA and an arti-
ficial selenoprotein MsrB from Clostridium sp., an anaerobic bac-
terium [29, 62]. It was shown that these proteins take advantage 
of incorporating selenocysteine as the catalytic residue, but they 
could not be reduced by thioredoxin, suggesting that the selen-
enic acid intermediate requires other reductants under physio-
logical conditions.
On the other hand, the use of selenocysteine in MsrB and 
MsrA is rare when viewed from the evolutionary perspective. 
The absolute majority of these enzymes are cysteine-containing 
proteins, and many of these are highly efficient in standard in 
vitro assays. Interestingly, Msrs are absent in many hyperther-
mophylic organisms because at higher temperatures, methio-
nine sulfoxide reduction may not require catalysis. By the same 
token, selenoprotein Msrs might be needed under conditions 
when their cysteine-containing counterparts are ineffective.
6. Aging and Msrs
Since the oxidative stress theory of aging was first intro-
duced half a century ago, free radicals and other ROS emerged 
as important factors that regulate the aging process [1, 78, 79]. 
Along with the idea of ROS-induced damage, defense mecha-
nisms received much attention, especially in the area of aging 
research, because efficient protection from oxidative stress and 
elimination of damage might delay the aging process. It has 
been shown that various antioxidant enzymes, such as catalase 
and SOD, could protect from oxidative stress and increase lifes-
pan in some model organisms [80–84]. As an antioxidant en-
Figure 4. Selenoprotein biosynthesis. Selenocysteine is inserted into protein at UGA codons with the help of various factors that form the seleno-
cysteine insertion machinery as shown in the figure. Sec-tRNASec, a tRNA specific for selenocysteine; SBP2, SECIS binding protein 2; EFSec, elon-
gation factor specific for Sec-tRNA.
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zyme, MsrA has also been examined, and it was found that its 
overexpression could extend lifespan by 70% in Drosophila [84]. 
Furthermore, knockout of MsrA in mice or yeast reduced lifes-
pan of these organisms [46, 85]. In contrast to MsrA, the effect 
of MsrB is less obvious. It was reported that overexpression of 
MsrB extends lifespan of yeast cells grown under caloric restric-
tion conditions, but not in cells grown in regular medium, i.e., 
conditions where MsrA could increase lifespan [86].
As mentioned above, MsrA and MsrB have clear differences 
in their ability for reduction of free methionine sulfoxide as well 
as in their cellular locations, and these differences might account 
for the observations in the aging studies. Much of the amino 
acid metabolism occurs in mitochondria, which is also the or-
ganelle that generates significant amounts of ROS [87–90]. Since 
methionine is one of the amino acids most susceptible to oxi-
dation by ROS, it is possible that it can serve as a defense sys-
tem through cyclic oxidation and reduction by mitochondria-
targeted Msrs. In addition, methionine is a precursor for other 
antioxidants and redox compounds, such as cysteine, taurine, 
and glutathione. Furthermore, S-adenosylmethionine, the prin-
cipal methyl donor in the cell, is also an intermediate in the me-
thionine metabolism, which may link Msr function to epigene-
tic regulation [34, 78, 91–93]. Possible negative effects of excess 
methionine as a factor that regulates lifespan should be also con-
sidered. For example, overflow of methionine may generate ex-
cessive amounts of homocysteine [94] (Figure 5). Even though 
efficient reduction of free methionine sulfoxide might be a factor 
in protecting cells from ROS and extending lifespan, it should be 
Figure 5. Methionine and methionine sulfoxide metabolism in mammals. Protein synthesis, methionine cycle and transsulfuration pathways rep-
resent the major uses of free methionine.
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viewed in the context of overall methionine metabolism under 
both stress and normal conditions. Finally, since MsrB1 is a sele-
noprotein, it would be important to examine its effect as well as 
the effect of dietary selenium on lifespan in mammals.
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